Perceived advantages and disadvantages of substance use in a dual diagnosis population with severe mental disorders and severe substance use disorder. Considering the self-medication hypothesis

References

• Martensson S, Düring SW, Johansen KS, et al. Time trends in co-occurring substance use and psychiatric illness (dual diagnosis) from 2000 to 2017 - a nationwide study of Danish register data. Nord J Psychiatry. 2022;77(4):411–419. doi: 10.1080/08039488.2022.2134921.
   PubMed Web of Science ®Google Scholar
• Mestre-Pinto J, Domingo-Salvany A, Torrens M. Comorbidity of substance use and mental disorders in Europe. Lisbon, Portugal: EuropeanMonitoring Centre for Drugs and Drug Addiction (EMCDDA); 2015.
   Google Scholar
• Mueser KT. Integrated treatment for dual disorders: a guide to effective practice. New York: Guilford Press; 2003.
   Google Scholar
• Glaser FB. The concept of dual diagnosis: some critical comments. In: Riley D, editor. Dual disorders: alcoholism, drug dependence and mental health. Ottawa: Canadian Centre on Substance Abuse; 1993. p. 49–59.
   Google Scholar
• Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict Behav. 1998;23(6):717–734. doi: 10.1016/S0306-4603(98)00073-2.
   PubMed Web of Science ®Google Scholar
• Gregg L, Barrowclough C, Haddock G. Reason for increased substance use in psychosis. Clin Psychol Rev. 2007;27(4):494–510. doi: 10.1016/j.cpr.2006.09.004.
   PubMed Web of Science ®Google Scholar
• Darke S. Pathways to heroin dependence: time to re-appraise self-medication. Addiction. 2012;108(4):659–667. doi: 10.1111/j1360-0443.2021.04001.x.
   PubMed Web of Science ®Google Scholar
• Haller M, Chassin L. Risk pathways among traumatic stress, posttraumatic stress disorder symptoms, and alcohol and drug problems: a test of four hypotheses. Psychol Addict Behav. 2014;28(3):841–851. doi: 10.1037/a0035878.
   PubMed Web of Science ®Google Scholar
• Lembke A. Time to abandon the self-medication hypothesis in patients with psychiatric disorders. Am J Drug Alcohol Abuse. 2012;38(6):524–529. doi: 10.3109/00952990.2012.694532.
   PubMed Web of Science ®Google Scholar
• Read JP, Merrill JE, Griffin MJ, et al. Posttraumatic stress symptoms and alcohol problems: self-medication or trait vulnerability? Am J Addict. 2014;23(2):108–116. doi: 10.1111/j.1521-0391.2013.12075.x.
   PubMed Web of Science ®Google Scholar
• Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142(11):1259–1264. doi: 10.1176/ajp.142.11.1259.
   PubMed Web of Science ®Google Scholar
• Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):287–289.
   PubMed Web of Science ®Google Scholar
• Bauer J, Okkels N, Munk-Jørgensen P. State of psychiatry in Denmark. Int Rev Psychiatry. 2012;24(4):295–300. doi: 10.3109/09540261.2012.692321.
   PubMed Web of Science ®Google Scholar
• Düring SW, Nordgaard J, Mårtensson S. Stability of admission diagnoses; data from a specialized in-patient treatment facility for dual diagnosis. Nord J Psychiatry. 2021;75(1):54–62. doi: 10.1080/08039488.2020.1793381.
   PubMed Web of Science ®Google Scholar
• Martensson S, Johansen KS, Krarup J, et al. REDD-PAC cohort description: researching dual diagnosis - prognosis and characteristics. J Dual Diagn. 2023;18(2):111–122. doi: 10.1080/15504263.2022.2055250.
   Web of Science ®Google Scholar
• Lykke J, Austin SF, Mørch MM. Cognitive milieu therapy and restraint within dual diagnosis populations. Ugeskr Laeger. 2008;170(5):339–343. https://www.ncbi.nlm.nih.gov/pubmed/18252162 (Kognitiv miljoterapi og tvang i behandling af dobbeltdiagnose.)
   PubMedGoogle Scholar
• Lykke J. R, Oestrich I, Austin SF, et al. The implementation and evaluation of cognitive milieu therapy for dual diagnosis inpatients: a pragmatic clinical trial. J Dual Diagn. 2010;6(1):58–72. doi: 10.1080/15504260903498763.
   Web of Science ®Google Scholar
• Kavanagh DJ, Trembath M, Shockley N, et al. The DrugCheck problem list: a new screen for substance use disorders in people with psychosis. Addict Behav. 2011;36(9):927–932. doi: 10.1016/j.addbeh.2011.05.004.
   PubMed Web of Science ®Google Scholar
• Berman A, Bergman H, Palmstierna T, et al. DUDIT-E, the drug use disorder identification test-E. Stockholm (Sweden): Department of Clinical Neuroscience, Karolinska Institutet; 2003.
   Google Scholar
• Grossman M. Individual behaviors and substance use: the role of price. Cambridge: National Bureau of Economic Research Cambridge; 2004.
   Google Scholar
• Bryden A, Roberts B, McKee M, et al. A systematic review of the influence on alcohol use of community level availability and marketing of alcohol. Health Place. 2012;18(2):349–357. doi: 10.1016/j.healthplace.2011.11.003.
   PubMed Web of Science ®Google Scholar
• Hayes RD, Chang C-K, Fernandes A, et al. Associations between substance use disorder Sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service. Drug Alcohol Depend. 2011;118(1):56–61. doi: 10.1016/j.drugalcdep.2011.02.021.
   PubMed Web of Science ®Google Scholar
• Heiberg IH, Jacobsen BK, Nesvåg R, et al. Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder. PLoS One. 2018;13(8):e0202028. doi: 10.1371/journal.pone.0202028.
   PubMed Web of Science ®Google Scholar
• Hjemsæter AJ, Bramness JG, Drake R, et al. Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study. BMC Psychiatry. 2019;19(1):101. doi: 10.1186/s12888-019-2077-8.
   PubMedGoogle Scholar
• Arendt M, Rosenberg R, Foldager L, et al. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry. 2005;187(6):510–515. doi: 10.1192/bjp.187.6.510.
   PubMedGoogle Scholar
• Baldaçara L, Ramos A, Castaldelli-Maia JM. Managing drug-induced psychosis. Int Rev Psychiatry. 2023;35(5–6):496–502. doi: 10.1080/09540261.2023.2261544.
   PubMedGoogle Scholar
• Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–773. doi: 10.1016/S2215-0366(16)00104-8.
   PubMed Web of Science ®Google Scholar
• Schweizer E, Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand Suppl. 1998;393(s393):95–101. doi: 10.1111/j.1600-0447.1998.tb05973.x.
   PubMedGoogle Scholar
• Barrowclough C, Haddock G, Wykes T, et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ. 2010;341(v24 3):c6325–c6325. doi: 10.1136/bmj.c6325.
   PubMedGoogle Scholar
• Noonan W, Moyers T. Motivational interviewing. J Subst Misuse. 1997;2(1):8–16. doi: 10.3109/14659899709084610.
   Google Scholar
• Smedslund G, Berg RC, Hammerstrøm KT, et al. Motivational interviewing for substance abuse. Campbell Syst Rev. 2011;7(1):1–126. doi: 10.4073/csr.2011.6.
   Google Scholar
• Brekke E, Lien L, Davidson L, et al. First-person experiences of recovery in co-occurring mental health and substance use conditions. ADD. 2017;10(1):13–24. doi: 10.1108/ADD-07-2016-0015.
   Google Scholar
• Ness O, Borg M, Davidson L. Facilitators and barriers in dual recovery: a literature review of first-person perspectives. Adv Dual Diagn. 2014;7(3):107–117. doi: 10.1108/ADD-02-2014-0007.
   Google Scholar
• Beck AT. Cognitive therapy: a 30-year retrospective. Am Psychol. 1991;46(4):368–375. doi: 10.1037//0003-066x.46.4.368.
   PubMed Web of Science ®Google Scholar
• Beck AT. Cognitive therapy: past, present, and future. J Consult Clin Psychol. 1993;61(2):194–198. doi: 10.1037//0022-006x.61.2.194.
   PubMed Web of Science ®Google Scholar
• McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am. 2010;33(3):511–525. doi: 10.1016/j.psc.2010.04.012.
   PubMed Web of Science ®Google Scholar
• Kane S. Ambivalence and resistance to change. Mental Health Nurs. 2004a;24(3):11.
   Google Scholar
• Kane S. Interviewing and ambivalence. Mental Health Nurs. 2004b;24(2):16.
   Google Scholar
• Larsen JL, Johansen KS, Nordgaard J, et al. Dual case study of continued use vs cessation of cannabis in psychosis: a theoretically informed approach to a hard problem. ADD. 2022;15(1):22–36. doi: 10.1108/ADD-11-2021-0013.
   Google Scholar
• Newman CF. Cognitive-behavioral therapy for alcohol and other substance use disorders: the beck model in action. J Cogn Ther. 2019;12(4):307–326. doi: 10.1007/s41811-019-00051-9.
   Web of Science ®Google Scholar
• World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines (Vol. 1). Geneva: World Health Organization; 1992.
   Google Scholar
• Berman AH, Bergman H, Palmstierna T, et al. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22–31. doi: 10.1159/000081413.
   PubMed Web of Science ®Google Scholar
• Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162(8):1403–1413. doi: 10.1176/appi.ajp.162.8.1403.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363–371. doi: 10.1056/NEJMra1511480.
   PubMed Web of Science ®Google Scholar
• Airagnes G, Ducoutumany G, Laffy-Beaufils B, et al. Alcohol withdrawal syndrome management: is there anything new? Rev Med Interne. 2019;40(6):373–379. doi: 10.1016/j.revmed.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Pergolizzi JVJr, Raffa RB, Rosenblatt MH. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management. J Clin Pharm Ther. 2020;45(5):892–903. doi: 10.1111/jcpt.13114.
   PubMed Web of Science ®Google Scholar
• Cavicchioli M, Vassena G, Movalli M, et al. Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review. Drug Alcohol Depend. 2020;212:108002. doi: 10.1016/j.drugalcdep.2020.108002.
   PubMed Web of Science ®Google Scholar
• Shafiei E, Hoseini AF, Bibak A, et al. High risk situations predicting relapse in self-referred addicts to bushehr province substance abuse treatment centers. Int J High Risk Behav Addict. 2014;3(2):e16381. doi: 10.5812/ijhrba.16381.
   PubMedGoogle Scholar
• Emiliussen J, Andersen K, Nielsen AS. How do family pressure, health and ambivalence factor into entering alcohol treatment? Experiences of people aged 60 and older with alcohol use disorder. Nordisk Alkohol Nark. 2017;34(1):28–42. doi: 10.1177/1455072516682639.
   PubMedGoogle Scholar
• Oser ML, McKellar J, Moos BS, et al. Changes in ambivalence mediate the relation between entering treatment and change in alcohol use and problems. Addict Behav. 2010;35(4):367–369. doi: 10.1016/j.addbeh.2009.10.024.
   PubMed Web of Science ®Google Scholar
• Ostrach B, Leiner C. “I didn’t want to be on suboxone at first…”–ambivalence in perinatal substance use treatment. J Addict Med. 2019;13(4):264–271. doi: 10.1097/ADM.0000000000000491.
   PubMed Web of Science ®Google Scholar
• Freeman AM, Tribe RH, Stott JC, et al. Open dialogue: a review of the evidence. Psychiatr Serv. 2019;70(1):46–59. doi: 10.1176/appi.ps.201800236.
   PubMed Web of Science ®Google Scholar
• Miller WR, Rollnick S. Motivational interviewing: preparing people for change. Book review. J Studies Alcohol. 2002;63(6):776–777. doi:10.15288/jsa.2002.63.776
   Google Scholar
• Buus N, Ong B, Einboden R, et al. Implementing open dialogue approaches: a scoping review. Fam Process. 2021;60(4):1117–1133. doi: 10.1111/famp.12695.
   PubMed Web of Science ®Google Scholar
• Galbusera L, Kyselo M. The difference that makes the difference: a conceptual analysis of the open dialogue approach. Psychosis,. 2018;10(1):47–54. doi: 10.1080/17522439.2017.1397734.
   Web of Science ®Google Scholar